HH pathway-related proteins have been shown to predict prognostic outcomes in advanced NSCLC patients, and overexpressions of SHH and Gli1 are strongly associated with poor prognostic outcomes. The gene discussed is SHH; the disease is non-small cell lung carcinoma.